BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacMillan, J. F.
Right arrow Articles by Johnstone, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacMillan, J. F.
Right arrow Articles by Johnstone, E. C.

The British Journal of Psychiatry 148: 128-133 (1986)
© 1986 The Royal College of Psychiatrists

Short-term outcome in trial entrants and trial eligible patients

JF MacMillan, TJ Crow, AL Johnson and EC Johnstone

Of 253 patients from nine medical centres identified with first episodes of schizophrenic illness, 17 did not achieve discharge during the period of trial recruitment. 120 entered a randomised controlled trial of neuroleptic medication and were followed-up, as were 116 who were eligible for the trial but did not enter it. Overall, 60% of the sample had relapsed within two years of discharge; age, sex, ethnic origin, duration of admission, social withdrawal before admission, and type of onset of illness were not significantly related to relapse. Relapse rates were lower on active trial or standard medication than placebo, but however assessed, outcome at this early stage was poor for many patients.


This article has been cited by other articles:


Home page
 Int J Soc PsychiatryHome page
S.-A. Chong, Mythily, A. Lum, Y. H. Chan, and P. McGorry
Determinants of Duration of Untreated Psychosis and the Pathway to Care in Singapore
International Journal of Social Psychiatry, March 1, 2005; 51(1): 55 - 62.
[Abstract] [PDF]

Home page
 Br. J. PsychiatryHome page
R. J. DRAKE, C. J. HALEY, S. AKHTAR, and S. W. LEWIS
Causes and consequences of duration of untreated psychosis in schizophrenia
The British Journal of Psychiatry, December 1, 2000; 177(6): 511 - 515.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
D. G. Robinson, M. G. Woerner, J. Ma.J. Alvir, S. Geisler, A. Koreen, B. Sheitman, M. Chakos, D. Mayerhoff, R. Bilder, R. Goldman, et al.
Predictors of Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder
Am J Psychiatry, April 1, 1999; 156(4): 544 - 549.
[Abstract] [Full Text]

Home page
 J PsychopharmacolHome page
G. Mercer, A. Finlayson, E. C. Johnstone, C. Murray, and D. G. C. Owens
A study of enhanced management in patients with treatment-resistant schizophrenia
J Psychopharmacol, January 1, 1997; 11(4): 349 - 356.
[Abstract] [PDF]

Home page
 BMJHome page
E. C Johnstone and R. Sandler
Treatment resistance in schizophrenia
BMJ, February 10, 1996; 312(7027): 325 - 326.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1986 The Royal College of Psychiatrists.